Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.

Neutralizing (nAbs) and high affinity binding antibodies may be critical for an efficacious HIV-1 vaccine. We characterized virus-specific nAbs and binding antibody responses over 21 months in eight HIV-1 subtype C chronically infected individuals with heterogeneous rates of disease progression. Aut...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T
বিন্যাস: Journal article
ভাষা:English
প্রকাশিত: 2012
_version_ 1826269977305415680
author Archary, D
Rong, R
Gordon, M
Boliar, S
Madiga, M
Gray, E
Dugast, A
Hermanus, T
Goulder, P
Coovadia, H
Werner, L
Morris, L
Alter, G
Derdeyn, C
Ndung'u, T
author_facet Archary, D
Rong, R
Gordon, M
Boliar, S
Madiga, M
Gray, E
Dugast, A
Hermanus, T
Goulder, P
Coovadia, H
Werner, L
Morris, L
Alter, G
Derdeyn, C
Ndung'u, T
author_sort Archary, D
collection OXFORD
description Neutralizing (nAbs) and high affinity binding antibodies may be critical for an efficacious HIV-1 vaccine. We characterized virus-specific nAbs and binding antibody responses over 21 months in eight HIV-1 subtype C chronically infected individuals with heterogeneous rates of disease progression. Autologous nAb titers of study exit plasma against study entry viruses were significantly higher than contemporaneous responses at study entry (p=0.002) and exit (p=0.01). NAb breadth and potencies against subtype C viruses were significantly higher than for subtype A (p=0.03 and p=0.01) or B viruses (p=0.03; p=0.05) respectively. Gp41-IgG binding affinity was higher than gp120-IgG (p=0.0002). IgG-FcγR1 affinity was significantly higher than FcγRIIIa (p<0.005) at study entry and FcγRIIb (p<0.05) or FcγRIIIa (p<0.005) at study exit. Evolving IgG binding suggests alteration of immune function mediated by binding antibodies. Evolution of nAbs was a potential marker of HIV-1 disease progression.
first_indexed 2024-03-06T21:33:39Z
format Journal article
id oxford-uuid:4582deee-e1db-407d-a25a-4ed42cc65252
institution University of Oxford
language English
last_indexed 2024-03-06T21:33:39Z
publishDate 2012
record_format dspace
spelling oxford-uuid:4582deee-e1db-407d-a25a-4ed42cc652522022-03-26T15:08:13ZCharacterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4582deee-e1db-407d-a25a-4ed42cc65252EnglishSymplectic Elements at Oxford2012Archary, DRong, RGordon, MBoliar, SMadiga, MGray, EDugast, AHermanus, TGoulder, PCoovadia, HWerner, LMorris, LAlter, GDerdeyn, CNdung'u, TNeutralizing (nAbs) and high affinity binding antibodies may be critical for an efficacious HIV-1 vaccine. We characterized virus-specific nAbs and binding antibody responses over 21 months in eight HIV-1 subtype C chronically infected individuals with heterogeneous rates of disease progression. Autologous nAb titers of study exit plasma against study entry viruses were significantly higher than contemporaneous responses at study entry (p=0.002) and exit (p=0.01). NAb breadth and potencies against subtype C viruses were significantly higher than for subtype A (p=0.03 and p=0.01) or B viruses (p=0.03; p=0.05) respectively. Gp41-IgG binding affinity was higher than gp120-IgG (p=0.0002). IgG-FcγR1 affinity was significantly higher than FcγRIIIa (p<0.005) at study entry and FcγRIIb (p<0.05) or FcγRIIIa (p<0.005) at study exit. Evolving IgG binding suggests alteration of immune function mediated by binding antibodies. Evolution of nAbs was a potential marker of HIV-1 disease progression.
spellingShingle Archary, D
Rong, R
Gordon, M
Boliar, S
Madiga, M
Gray, E
Dugast, A
Hermanus, T
Goulder, P
Coovadia, H
Werner, L
Morris, L
Alter, G
Derdeyn, C
Ndung'u, T
Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
title Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
title_full Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
title_fullStr Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
title_full_unstemmed Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
title_short Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
title_sort characterization of anti hiv 1 neutralizing and binding antibodies in chronic hiv 1 subtype c infection
work_keys_str_mv AT archaryd characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT rongr characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT gordonm characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT boliars characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT madigam characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT graye characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT dugasta characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT hermanust characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT goulderp characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT coovadiah characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT wernerl characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT morrisl characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT alterg characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT derdeync characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection
AT ndungut characterizationofantihiv1neutralizingandbindingantibodiesinchronichiv1subtypecinfection